43.00
4.26%
1.94
前日終値:
$41.06
開ける:
$42.36
24時間の取引高:
114.37K
Relative Volume:
0.16
時価総額:
$3.29B
収益:
$399.58M
当期純損益:
$-54.04M
株価収益率:
-57.33
EPS:
-0.75
ネットキャッシュフロー:
$40.13M
1週間 パフォーマンス:
-2.22%
1か月 パフォーマンス:
-0.96%
6か月 パフォーマンス:
+89.50%
1年 パフォーマンス:
+61.41%
Veracyte Inc Stock (VCYT) Company Profile
名前
Veracyte Inc
セクター
電話
(650) 243-6300
住所
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
VCYT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
42.95 | 3.29B | 399.58M | -54.04M | 40.13M | -0.75 |
TMO
Thermo Fisher Scientific Inc
|
560.87 | 213.05B | 42.37B | 6.14B | 7.78B | 15.95 |
DHR
Danaher Corp
|
240.71 | 171.63B | 23.74B | 3.89B | 4.98B | 5.24 |
A
Agilent Technologies Inc
|
146.03 | 40.96B | 6.51B | 1.29B | 1.37B | 4.42 |
IQV
Iqvia Holdings Inc
|
198.37 | 35.93B | 15.32B | 1.41B | 1.96B | 7.62 |
IDXX
Idexx Laboratories Inc
|
429.76 | 34.28B | 3.84B | 866.24M | 792.60M | 10.37 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-05 | ダウングレード | Goldman | Buy → Neutral |
2024-11-15 | 開始されました | Wolfe Research | Outperform |
2024-10-16 | 開始されました | UBS | Buy |
2024-10-10 | 開始されました | Guggenheim | Buy |
2024-02-23 | 繰り返されました | Needham | Buy |
2023-01-18 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
2022-01-07 | 開始されました | Stephens | Overweight |
2021-11-18 | 再開されました | Goldman | Buy |
2021-06-15 | 開始されました | Raymond James | Outperform |
2021-02-18 | 再開されました | Needham | Buy |
2021-01-28 | 開始されました | Truist | Buy |
2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
2020-09-09 | 開始されました | Morgan Stanley | Underweight |
2019-07-31 | 開始されました | Lake Street | Buy |
2019-07-02 | 開始されました | Needham | Buy |
2018-11-29 | ダウングレード | Janney | Buy → Neutral |
2018-10-31 | アップグレード | Janney | Neutral → Buy |
2017-11-07 | ダウングレード | Janney | Buy → Neutral |
2017-11-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
2017-08-31 | 再開されました | BTIG Research | Buy |
2016-11-14 | 再開されました | Leerink Partners | Outperform |
2015-12-18 | 開始されました | Cantor Fitzgerald | Buy |
2015-06-11 | 繰り返されました | Leerink Partners | Outperform |
2013-11-26 | 開始されました | William Blair | Outperform |
すべてを表示
Veracyte Inc (VCYT) 最新ニュース
Veracyte Inc (VCYT) Shares Gap Down to $40.865 on Jan 14 - GuruFocus.com
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
Catherine Wood's Strategic Reduction in Veracyte Inc Shares - GuruFocus.com
Diversified Trust Co Cuts Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Has Found A Path To Profitability - Yahoo Finance
Veracyte Gains 44% in a Year: What's Driving the Stock? - MSN
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks - Yahoo Finance
Veracyte director Karin Eastham sells shares worth $403,005 By Investing.com - Investing.com Australia
Insider Selling: Veracyte, Inc. (NASDAQ:VCYT) Director Sells 10,000 Shares of Stock - MarketBeat
Veracyte director Karin Eastham sells shares worth $403,005 - Investing.com
Veracyte Inc (VCYT) Stock Price Up 3.58% on Jan 6 - GuruFocus.com
Principal Financial Group Inc. Lowers Holdings in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now - MSN
Brokerages Set Veracyte, Inc. (NASDAQ:VCYT) Target Price at $41.13 - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Sees Significant Decrease in Short Interest - MarketBeat
Stifel Financial Corp Sells 19,420 Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte (NASDAQ:VCYT) Shares Gap DownShould You Sell? - MarketBeat
Geode Capital Management LLC Raises Holdings in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Barclays PLC Buys 85,033 Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
HighTower Advisors LLC Makes New Investment in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
HighTower Advisors LLC Takes $554,000 Position in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories - Zacks Investment Research
Veracyte CEO Marc Stapley sells shares worth $242,736 By Investing.com - Investing.com Canada
Veracyte CEO Marc Stapley sells shares worth $242,736 - Investing.com India
Lord Abbett & CO. LLC Purchases New Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte - Yahoo Finance
3 Medical Instruments Industry Stocks To Buy On The GenAI Wave - Barchart
Veracyte, Inc. (NASDAQ:VCYT) Shares Purchased by Fmr LLC - MarketBeat
US Exchange: 3 Stocks That May Be Trading Below Fair Value - Simply Wall St
Jane Street Group LLC Raises Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now - MSN
Veracyte (VCYT) Just Flashed Golden Cross Signal: Do You Buy? - MSN
Why Veracyte, With 55% Growth In 2024, Is An Outlier In Cancer Diagnostics - Yahoo! Voices
Veracyte (VCYT) Shares Rebounded in Q3 - Insider Monkey
Neo Ivy Capital Management Buys Shares of 24,116 Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen - Yahoo Finance
Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68% - Yahoo Finance
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar - Yahoo Finance
Veracyte: Getting Frothy (NASDAQ:VCYT) - Seeking Alpha
Zacks Investment Management Makes New $1.12 Million Investment in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Wellington Management Group LLP Cuts Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Cerity Partners LLC Purchases New Shares in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
48,193 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by XTX Topco Ltd - MarketBeat
Veracyte Inc (VCYT) 財務データ
収益
当期純利益
現金流量
EPS
Veracyte Inc (VCYT) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
EASTHAM KARIN | Director |
Jan 02 '25 |
Option Exercise |
5.28 |
10,000 |
52,800 |
28,497 |
EASTHAM KARIN | Director |
Jan 02 '25 |
Sale |
40.30 |
10,000 |
403,006 |
18,497 |
大文字化:
|
ボリューム (24 時間):